[Perinatal brain damage--from neuroprotection to neuroregeneration using cord blood stem cells]

Arne Jensen1, Hans-Martin Vaihinger, Carola Meier

  • 1Zentrum für Perinatalmedizin, Experimentelle Perinatologie, Universitätsfrauenklinik Bochum, Ruhr-Universität Bochum. arne.jensen@ruhr-uni-bochum.de

Medizinische Klinik (Munich, Germany : 1983)
|March 3, 2004
PubMed

Insights

Perinatal hypoxic-ischemic insults cause brain damage in about 1,000 German children annually. Research explores cord blood stem cells for neuroregeneration to mitigate this damage.

Area of Science:

  • Perinatology
  • Neuroscience
  • Regenerative Medicine

Background:

  • Approximately 1,000 children in Germany annually experience brain damage from perinatal hypoxic-ischemic insults.
  • These insults can lead to various neurological impairments, including spastic paresis, choreoathetosis, ataxia, and sensorimotor dysfunction.
  • The significant physical, emotional, and financial burden necessitates advanced therapeutic strategies.

Purpose of the Study:

  • To highlight the need for effective neuroprotective and regenerative therapies post-insult.
  • To explore the potential of novel treatments for reducing cerebral morbidity in newborns.
  • To investigate the application of cord blood-derived stem cells for neuroregeneration.

Main Methods:

  • Review of clinical concepts for decreasing cerebral morbidity.
  • Analysis of experimental pilot studies on neuroprotection.
  • Focus on current research into cord blood stem cell applications for brain injury.

Main Results:

  • Clinical concepts have shown effectiveness in reducing morbidity over the past decade.
  • Experimental pilot studies show promise for neuroprotective interventions.
  • Current research is actively investigating cord blood stem cells for neuroregeneration.

Conclusions:

  • While clinical measures have improved, brain damage cannot always be prevented.
  • Developing post-insult therapeutic measures with neuroprotective effects is crucial.
  • Cord blood-derived stem cells represent a promising avenue for neuroregeneration in affected children.